News

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and ...
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
The B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...